|Número de publicación||US20070055281 A1|
|Tipo de publicación||Solicitud|
|Número de solicitud||US 11/528,165|
|Fecha de publicación||8 Mar 2007|
|Fecha de presentación||27 Sep 2006|
|Fecha de prioridad||26 Ene 1994|
|También publicado como||CA2404916A1, CA2404916C, CN1427700A, CN1427700B, DE60117524D1, DE60117524T2, EP1272131A2, EP1272131B1, US6726691, US7959638, US7967827, US8152813, US8226717, US8246681, US8317865, US20020161373, US20030220648, US20030233096, US20040167562, US20060241644, US20060276819, US20070055266, US20070055267, US20070055277, US20070055278, US20070055280, US20070055284, US20070055285, US20070055300, US20070055382, US20070225705, US20080058827, US20080065087, US20080065089, US20080065190, US20080071283, US20080132935, US20080140079, US20080140084, US20080319444, WO2001076514A2, WO2001076514A3|
|Número de publicación||11528165, 528165, US 2007/0055281 A1, US 2007/055281 A1, US 20070055281 A1, US 20070055281A1, US 2007055281 A1, US 2007055281A1, US-A1-20070055281, US-A1-2007055281, US2007/0055281A1, US2007/055281A1, US20070055281 A1, US20070055281A1, US2007055281 A1, US2007055281A1|
|Inventores||Reynaldo Osorio, Marialulu Follmer, Richard Layne, Ryan Boucher, Karen Talmadge, Joseph Basista, Mark Reiley, Arie Scholten, Robert Scribner, Michael Reo|
|Cesionario original||Kyphon Inc.|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (99), Citada por (34), Clasificaciones (43), Eventos legales (5)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
This application is a divisional of co-pending U.S. patent application Ser. No. 10/783,723, filed 20 Feb. 2004, and entitled “Methods and Devices for Treating Fractured and/or Diseased Bone,” which is a divisional of U.S. patent application Ser. No. 09/827,260, filed 5 Apr. 2001 (now U.S. Pat. No. 6,726,691), which claims the benefit of U.S. Provisional Patent Application No. 60/194,685, filed 5 Apr. 2000 (Expired), and which is also a continuation-in-part of co-pending U.S. patent application Ser. No. 10/346,618, filed 17 Jan. 2003, which is a divisional of U.S. patent application Ser. No. 09/597,646, filed 20 Jun. 2000 (now U.S. Pat. No. 6,716,216), which is a continuation-in-part of U.S. patent application Ser. No. 09/134,323, filed 14 Aug. 1998 (now U.S. Pat. No. 6,241,734), each of which is incorporated herein by reference. This application is also a continuation-in-part of co-pending U.S. patent application Ser. No. 10/958,600, filed 5 Oct., 2004, and entitled “Systems and Methods for Treating Fractured or Diseased Bone Using Expandable Bodies,” which is a divisional of U.S. patent application Ser. No. 09/754,451, filed 4 Jan. 2001 (now U.S. Pat. No. 6,899,719), which is a continuation of U.S. patent application Ser. No. 08/871,114, filed 9 Jun. 1997 (now U.S. Pat. No. 6,248,110), which is a continuation-in-part of U.S. patent application Ser. No. 08/659,678, filed 5 Jun. 1996 (now U.S. Pat. No. 5,827,289), which is a continuation-in-part of U.S. patent application Ser. No. 08/485,394, filed 7 Jun. 1995 (Abandoned), which is a continuation-in-part of U.S. patent application Ser. No. 08/188,224, filed 26 Jan. 1994 (Abandoned), each of which is incorporated herein by reference.
This application is also related to the following co-pending United States patent applications, which are commonly owned and have been filed on the same day as this application: (1) U.S. patent application Ser. No. (to be supplied, attorney docket 17207-For Div 11) entitled “Methods For Treating Fractured and/or Diseased Bone By Introduction Of A Bone Filling Material” (2) U.S. patent application Ser. No. (to be supplied, attorney docket 17207-For Div 12), entitled “Methods For Treating Fractured and/or Diseased Bone By Introduction Of Different Bone Filling Materials.”
1. Field of the Invention
The present invention relates to devices and methods for treating fractured and/or diseased bone. More specifically, the present invention relates to devices and methods for repairing, reinforcing and/or treating fractured and/or diseased bone using various devices, including cavity-forming devices.
2. Description of the Background
Normal healthy bone is composed of a framework made of proteins, collagen and calcium salts. Healthy bone is typically strong enough to withstand the various stresses experienced by an individual during his or her normal daily activities, and can normally withstand much greater stresses for varying lengths of time before failing. However, osteoporosis or a host of other diseases, including such diseases as breast cancer, hemangiomas, osteolytic metastases or spinal myeloma lesions, as well as the long term excessive use of alcohol, tobacco and/or various drugs, can affect and significantly weaken healthy bone over time. If unchecked, such factors can degrade bone strength to a point where the bone is especially prone to fracture, collapse and/or is unable to withstand even normal daily stresses.
Unfortunately, losses in bone strength are often difficult to discover until bone integrity has already been seriously compromised. For instance, the effects of osteoporosis are often not discovered until after a bone fracture has already occurred, at which time much of the patient's overall bone strength has typically weakened to dangerous levels. Moreover, as most bone development occurs primarily during childhood and early adulthood, long-term losses in bone strength are typically irreversible. In addition, many bone diseases, including osteoporosis, cancer, and other bone-related disorders, are not routinely curable at our current stage of medical development.
For many individuals in our aging world population, undiagnosed and/or untreatable bone strength losses have already weakened these individuals' bones to a point that even normal daily activities pose a significant threat of fracture. For example, when the bones of the spine are sufficiently weakened, the compressive forces in the spine can often cause fracture and/or deformation of the vertebral bodies. For sufficiently weakened bone, even normal daily activities like walking down steps or carrying groceries can cause a collapse of one or more spinal bones, much like a piece of chalk collapses under the compressive weight of a human foot. A fracture of the vertebral body in this manner is typically referred to as a vertebral compression fracture. Researchers estimate that at least 25 percent of all women, and a somewhat smaller percentage of men, over the age of 50 will suffer one or more vertebral compression fractures due to osteoporosis alone. In the United States, it is estimated that over 700,000 vertebral compression fractures occur each year, over 200,000 of which require some form of hospitalization. Other commonly occurring fractures resulting from weakened bones can include hip, wrist, knee and ankle fractures, to name a few.
Fractures such as vertebral compression fractures often result in episodes of pain that are chronic and intense. Aside from the pain caused by the fracture itself, the involvement of the spinal column can result in pinched and/or damaged nerves, causing paralysis, loss of function, and intense pain which radiates throughout the patient's body. Even where nerves are not affected, however, the intense pain associated with all types of fractures is debilitating, resulting in a great deal of stress, impaired mobility and other long-term consequences. For example, progressive spinal fractures can, over time, cause serious deformation of the spine (“kyphosis”), giving an individual a hunched-back appearance, and can also result in significantly reduced lung capacity and increased mortality.
Until recently, treatment options for vertebral compression fractures, as well as other serious fractures and/or losses in bone strength, were extremely limited—mainly pain management with strong oral or intravenous medications, reduced activity, bracing and/or radiation therapy, all with mediocre results. Because patients with these problems are typically older, and often suffer from various other significant health complications, many of these individuals are unable to tolerate invasive surgery. In addition, to curb further loss of bone strength, many patients are given hormones and/or vitamin/mineral supplements—again with mediocre results and often with significant side effects.
Over the past decade, a technique called vertebroplasty has been introduced into the United States. Vertebroplasty involves the injection of a flowable reinforcing material, usually polymethylmethacrylate (PMMA—commonly known as bone cement), into a fractured, weakened, or diseased vertebral body. Shortly after injection, the liquid filling material hardens or polymerizes, desirably supporting the vertebral body internally, alleviating pain and preventing further collapse of the injected vertebral body.
While vertebroplasty has been shown to reduce some pain associated with vertebral compression fractures, this procedure has certain inherent drawbacks. The most significant danger associated with vertebroplasty is the inability of the practitioner to control the flow of liquid bone cement during injection into a vertebral body. Although the location and flow patterns of the cement can be monitored by CT scanning or x-ray fluoroscopy, once the liquid cement exits the injection needle, it naturally follows the path of least resistance within the bone, which is often through the cracks and/or gaps in the cancellous and/or cortical bone. Moreover, because the cancellous bone resists the injection of the bone cement and small diameter needles are typically used in vertebroplasty procedures, extremely high pressures are required to force the bone cement through the needle and into the vertebral body. Bone cement, which is viscous, is difficult to inject through small diameter needles, and thus many practitioners choose to “thin out” the cement mixture to improve cement injection, which ultimately exacerbates the leakage problems. In a recent study where 37 patients with bone metastases or multiple myeloma were treated with vertebroplasty, 72.5% of the procedures resulted in leakage of the cement outside the vertebral body. Cortet B. et al., Percutaneous Vertebroplasty in Patients With Osteolytic Metastases or Multiple Myeloma (1998). Moreover, where the practitioner attempts to “thin out” the cement by adding additional liquid monomer to the cement mix, the amount of unpolymerized or “free” monomer increases, which can ultimately be toxic to the patient.
Another drawback of vertebroplasty is due to the inability to visualize (using CT scanning or x-ray fluoroscopy) the various venous and other soft tissue structures existent within the vertebra. While the position of the needle within the vertebral body is typically visualized, the location of the venous structures within the vertebral body are not. Accordingly, a small diameter vertebroplasty needle can easily be accidentally positioned within a vein in the vertebral body, and liquid cement pumped directly into the venous system, where the cement easily passes out the anterior and/or posterior walls of the vertebrae through the anterior external venous plexus or the basivertebral vein.
Another significant drawback inherent in vertebroplasty is the inability of this procedure to restore the vertebral body to a pre-fractured condition prior to the injection of the reinforcing material. Because the bone is fractured and/or deformed, and not repositioned prior to the injection of cement, vertebroplasty essentially “freezes” the bone in its fractured condition. Moreover, it is highly unlikely that a traditional vertebroplasty procedure could be capable of restoring significant pre-fracture anatomy—because bone cement flows towards the path of least resistance, any en-masse movement of the cortical bone would likely create gaps in the interior and/or walls of the vertebral body through which the bone cement would then immediately flow.
A more recently developed procedure for treating fractures such as vertebral compression fractures and other bone-related disorders is known as Kyphoplasty™. See, for example, U.S. Pat. Nos. 4,969,888 and 5,108,404. In Kyphoplasty, an expandable body is inserted through a small opening in the fractured or weakened bone, and then expanded within the bone. This procedure compresses the cancellous bone, and desirably moves the fractured bone to its pre-fractured orientation, creating a cavity within the bone that can be filled with a settable material such as cement or any number of synthetic bone substitutes. In effect, the procedure “sets” the bone at or near its pre-fracture position and creates an internal “cast,” protecting the bone from further fracture and/or collapse. This procedure is of course suitable for use in various other bones as well.
While Kyphoplasty can restore bones to a pre-fractured condition, and injected bone filler is less likely to leak out of the vertebral body during a Kyphoplasty procedure, Kyphoplasty requires a greater number of surgical tools than a vertebroplasty procedure, at an increased cost. Moreover, Kyphoplasty tools are typically larger in diameter than vertebroplasty tools, and thus require larger incisions and are generally more invasive.
The present invention overcomes many of the problems and disadvantages associated with current strategies and designs in medical procedures to repair, reinforce and/or treat weakened, diseased and/or fractured bone.
The invention provides methodologies whereby a percutaneous path is established into a vertebral body, having an interior volume occupied, at least in part, by cancellous bone. A first bone filling material is conveyed through the percutaneous path into a region of the cancellous bone. A second bone filling material is conveyed through the percutaneous path into the region. The first and second bone filling materials can, e.g., incrementally create then enlarge a compressed region of cancellous bone, or displace the fractured cortical bone in increments.
One aspect of the invention provides a method that selects a vertebral body having an interior volume occupied, at least in part, by cancellous bone. The method establishes a percutaneous path into the vertebral body. The method conveys a first bone filling material through the percutaneous path to compress a region of the cancellous bone. The method conveys a second bone filling material through the percutaneous path to enlarge the region. The method leaves the first and second bone filling materials in the enlarged region.
Another aspect of the invention provides a method that selects a vertebral body having an interior volume occupied, at least in part, by cancellous bone, the vertebral body having at least one cortical plate that is depressed due to fracture. The method establishes a percutaneous path into the vertebral body. The method inserts a first bone filling material through the percutaneous path into the vertebral body causing the fractured cortical plate to be displaced. The method inserts a second bone filling material through the percutaneous path into the vertebral body causing further displacement of the fractured cortical plate.
Other objects, advantages, and embodiments of the invention are set forth in part in the description which follows, and in part, will be obvious from this description, or may be learned from the practice of the invention.
As embodied and broadly described herein, the present invention is directed to surgical methods for repairing, reinforcing and/or treating weakened, diseased and/or fractured bone. The present invention is further directed to various devices for facilitating such surgical methods.
The spinal canal 150 is located on the posterior (i.e. back) side of each vertebra 100. The spinal cord 151 passes through the spinal canal 150. A vertebral arch 135 surrounds the spinal canal 150. Left and right pedicles 120 of the vertebral arch 135 adjoin the vertebral body 105. The spinous process 130 extends from the posterior of the vertebral arch 135, as do the left and right transverse processes 125 and the mamillary processes 126.
In one embodiment of the present invention, a surgical method comprises inserting an insertion device 350 (see
The insertion device 350 is preferably comprised of a strong, non-reactive, and medical grade material such as surgical steel. If desired, the insertion device 350 is attached to a manipulating assembly which is comprised of a non-reactive and medical grade material including, but not limited to, acrylonitrile-butadiene-styrene (ABS), polyethylene, polypropylene, polyurethane, Teflon, or surgical steel.
As shown in
In one preferred embodiment, the distal end 351 of the insertion device 350 is positioned in the vertebral body 105, preferably at a location towards the posterior side of the vertebral body 105. If desired, the distal end 351 could be positioned in various locations throughout the vertebral body 105, including towards the anterior side. Once in position, the stylet 349 of the insertion device 350 may be removed, see
In one embodiment, shown in
The balloon catheter 200, which will be described in more detail below, is sized or folded to fit through the hollow interior of the shaft 348 and into a vertebral body 105. Once in a desired position within the vertebral body 105, the balloon catheter 190 is filled with a pressurized filling medium 275 appropriate for use in medical applications including, but not limited to, air, nitrogen, saline or water. See
In one embodiment, the catheter 201 is expanded to any appropriate volume which creates a cavity 170 within the vertebral body 105. In a preferred embodiment, the catheter 201 is expanded to at least 0.20 cc in volume, but could be expanded to significantly greater sizes, such as 1, 2, 4, 6 or 8 cc, depending upon bone quality and density. After cavity creation, the catheter 201 is deflated (see
If desired, a portion of the balloon catheter 201 could be temporarily or permanently left within a vertebral body 105. For example, after cavity formation and removal of the inflation medium, the deflated expanded section of the balloon catheter 201 could be refilled with bone filler 180 and left within the vertebral body 105. Alternatively, the inflation medium 275 could comprise bone filler 180. After the balloon catheter 201 is filled with such an inflation medium, at least a portion of the catheter 201 could be left permanently within the cavity 170. In an alternate embodiment, the catheter 201 which is intended to remain with the cavity 170 could comprise a bio-absorbable material and/or fabric/mesh material as the expandable structure.
In creating the cavity 170, the inflation of the catheter 201 causes the expandable material 210 to press against the cancellous bone 115 which may form a compressed bone region or “shell” 172 along much of the periphery of the cavity 170. This shell 172 will desirably inhibit or prevent bone filler 180 from exiting the cavity 170, thereby inhibiting extravazation of the bone filler and/or facilitating pressurization of the bone filler 180, if desired, within the cavity. As the pressure in the cavity 170 increases, the walls of the cavity 170 will desirably be forced further outward by the bone filler 180, compressing additional cancellous bone within the vertebral body 105 and/or increasing the size of the cavity 170. If sufficient pressure is available, and integrity of the shell 172 can be maintained without significant leakage of bone filler 180, pressures capable of moving fractured cortical bone can be developed.
In one embodiment of the present invention, after cavity formation, an amount of a material, such as a bone filler 180, is introduced through the shaft 348 into the vertebral body 105 under low pressure. The amount of bone filler will desirably be more than the volume of the cavity 170, however, less bone filler may be introduced with varying results. Once the cavity 170 is substantially filled, the continued introduction of bone filler 180 will desirably pressurize the bone filler 180 in the cavity 170 such that the increased pressure will cause at least a portion of the walls of the cavity to move outward, thereby enlarging the cavity 170 and further compressing cancellous bone and/or moving cortical bone. Desirably, introduction of the bone filler 180 will continue until bone filler leak from the vertebral body appears imminent, the cortical bone has regain its pre-fractured position and/or the practitioner determines that sufficient bone filler 180 has been injected into the bone. If desired, the physician can utilize the cavity-forming device to create additional cavities for bone filler, or the shaft 348 can be removed from the vertebral body to completed the procedure.
The bone filler 180 could be any appropriate filling material used in orthopedic surgery, including, but not limited to, allograft or autograft tissue, hydroxyapatite, epoxy, PMMA bone cement, or synthetic bone substitutes such Osteoset® from Wright Medical Technology, medical grade plaster of paris, Skeletal Repair System (SRS®) cement from Norian Corporation, or Collagraft from Zimmer. As bone filler 180 is introduced into the vertebral body 105, the introduction is desirably monitored by x-ray fluoroscopy, or any other appropriate monitoring device or method, to ensure that bone filler 180 does not flow outside of the vertebral body 105. To facilitate visualization, the bone filler 180 may be mixed with a fluoroscopic agent, such as radio opaque barium sulfate. In another embodiment, the bone filler 180 could comprise a mixture of bone cement and a thixotropic material which desirably limits and/or prevents extravazation of the bone cement.
In an alternate embodiment of the disclosed method, shown in
The first bone filler will desirably comprise a material that can be introduced into the cavity, but which will resist extravazation out of the cavity and/or vertebral body when the second bone filler is injected into the cavity. In one embodiment of the invention, the first and second bone fillers comprise bone cement, with the first bone cement being more resistant to extravazation than the second bone cement. For example, the ingredients of the first bone cement could be specifically tailored such that the first bone cement cures faster than the second bone cement. Alternatively, the first bone cement could be prepared and/or introduced into the vertebral body before the second bone cement, allowing the first bone cement to partially or fully cure before the second bone cement. Alternatively, the curing and/or hardening of the first bone cement could be accelerated (by applying heat, for example) or curing and/or hardening of the second bone cement could be retarded (by cooling, for example). In another embodiment, the first and second bone fillers comprise bone cement, with the first bone cement desirably being more viscous than the second bone cement. In another alternate embodiment, the first bone filler comprises an expandable structure, such as a stent.
In another embodiment, the first bone filler comprises a material more viscous than the second bone filler, the first and second bone fillers comprising different materials. In another embodiment, the first bone filler comprises a material which is more resistant to extravazation into the cancellous bone than the second bone filler. In another embodiment, the first bone filler comprises a material having particles generally larger than particles in the second bone filler. In a further embodiment, the particles of the first bone filler are generally larger than the average pore size within the cancellous bone. In another embodiment, the first bone filler comprises a settable material, such as a two-part polyurethane material or other curable bio-material.
By creating cavities and/or preferred flowpaths within the cancellous bone, the present invention obviates the need for extremely high pressure injection of bone filler into the cancellous bone. If desired, the bone filler could be injected into the bone at or near atmospheric and/or ambient pressures, or at pressures less than approximately 400 pounds per square inch, using bone filler delivery systems such as those described in co-pending U.S. patent application Ser. No. 09/134,323, which is incorporated herein by reference. Thus, more viscous bone fillers (such as, for example, thicker bone cement) can be injected into the bone under low pressures (such as, for example, exiting the delivery device at a delivery pressure at or near ambient or atmospheric pressure), reducing opportunities for cement leakage and/or extravazation outside of the bone.
The present invention also includes cavity-forming devices constructed in accordance with the teachings of the disclosed invention. In one embodiment, the cavity-forming device comprises a balloon catheter 201, as shown in
For example, a balloon catheter 201 constructed in accordance with one preferred embodiment of the present invention, suitable for use with an 11-gauge needle, would comprise a hollow stainless steel hypodermic tube 205, having an outer diameter of 0.035 inches and a length of 10.75 inches. One or more openings 250 are formed approximately 0.25 inches from the distal end of the tube 205. In a preferred embodiment, the distal end 206 of the hollow tube 205 is sealed closed using any means well known in the art, including adhesive (for example, UV 198-M adhesive commercially available from Dymax Corporation—cured for approximately 15 minutes under UV light).
In one embodiment, the hollow tube 205 is substantially surrounded by an expandable structure 210 comprising an extruded tube of polyurethane (for example, TEXIN® 5290 polyurethane, available commercially from Bayer Corporation). In one embodiment, the polyurethane tube has an inner diameter of 0.046 inches, an outer diameter of 0.082 inches, and a length of 9-½ inches. The distal end of the polyurethane tube is bonded to the distal end 206 of the hollow tube 205 by means known in the art, such as by a suitable adhesive (for example, UV 198-M adhesive). Alternatively, the polyurethane tube may be heat sealed about the distal end 206 of the hollow tube 205 by means well known in the art. A ¾ inch long piece of heat shrink tubing 215 (commercially available from Raychem Corporation), having a 3/16 inch outer diameter, may be secured around the proximal end of the polyurethane tubing. In one embodiment, the proximal end of the hollow tubing 205 is inserted into the fitting 220 and the heat shrink tubing 215 is desirably bonded into the fitting 220 using a suitable adhesive known in the art, such as UV 198-M. The fitting 220, which may be a Luer T-fitting, commercially available from numerous parts suppliers, may be made of any appropriate material known to those of skill in the art. The fitting 220 comprises one or more ports 222, 224 for attachment to additional instruments, such as pumps and syringes (not shown). If desired, the hollow tube 205 can similarly be bonded into the fitting 220 using a suitable adhesive. Alternatively, as shown in
The hollow tube 205 and one or more openings 250 facilitate the withdrawal of inflation medium from the catheter during the disclosed procedures. When a catheter is deflated, the expandable structure 210 will normally collapse against the tube 205, which can often seal closed the lumen (in the absence of at least one secondary withdrawal path) and inhibit further withdrawal of inflation medium from the expanded structure 210 of a catheter. However, in an embodiment of the disclosed invention, the one or more openings 250 near the distal end of the tube 205 allow inflation medium 275 to be drawn through the hollow hypodermic tube 205, further deflating the expandable structure 210. The strong walls of the hollow hypodermic tube 205 resist collapsing under the vacuum which evacuates the inflation medium, maintaining a flowpath for the inflation medium and allowing the inflation medium to be quickly drawn out of the catheter, which desirably permits deflation of the catheter in only a few seconds.
In the disclosed embodiment, as the catheter 201 is inflated, the inflation medium 275 will typically seek to fill the entire lumen between the expandable structure 210 and the hollow tube 205, thus expanding the catheter 201 along the entire length of the expandable structure 210. However, because much of the catheter 201 is located within the lumen of the shaft 348, with the distal end 206 of the catheter 201 extending into the vertebral body 105, the shaft 348 will desirably constrain expansion of the expandable structure 210, causing the expandable structure 210 to expand primarily at the distal end 206 of the catheter 200. Desirably, further insertion or withdrawal of the catheter 201 will alter the amount of the expandable structure 210 extending from the distal end of the shaft 348, thereby increasing or decreasing the length of the expandable structure 210 that is free to expand within the vertebral body 105. By choosing the amount of catheter 201 to insert into the vertebral body 105, the practitioner can alter the length of the expandable structure, and ultimately the size of the cavity 170 created by the catheter 201, during the surgical procedure. Therefore, the disclosed embodiments can obviate and/or reduce the need for multiple catheters of varying lengths. If desired, markings 269 (see
In an alternate embodiment, shown in
As previously noted, in the disclosed embodiment, the expandable structure is desirably secured to the distal end of the hollow tube, which will facilitate recovery of fragments of the expandable structure 210 if the expandable structure 210 is torn or damaged, such as by a complete radial tear. Because the hollow tube 205 will desirably remain attached to the fragments (not shown) of the expandable structure 210, these fragments can be withdrawn from the vertebral body 105 with the hollow tube 205. In addition, the distal attachment will desirably prevent and/or reduce significant expansion of the expandable structure 210 along the longitudinal axis of the hollow tube 205.
In use, a cavity-forming device 300 compresses cancellous bone and/or forms a cavity in a manner similar to the embodiments previously described. However, once the cavity is formed and withdrawal of the device 300 is desired, the cap 310 can be rotated, twisting the expandable material 210 relative to the fitting 220 and drawing the expandable structure 210 against the hollow tube 205, desirably minimizing the overall outside diameter of the expandable portion of the device 300. The device 300 can then easily be withdrawn through the shaft 348. Even where the expandable structure 210 has plastically deformed, or has failed in some manner, the present embodiment allows the expandable structure 210 to be wrapped around the hollow tube 205 for ease of withdrawal and/or insertion. Alternatively, the hollow tube 205 may be capable of movement relative to the longitudinal axis of the fitting 220, which would further stretch and/or contract the expandable structure 210 against the hollow tube 205.
As shown in
After removal of the device(s), bone filler (not shown) may be introduced through the shaft 348. Desirably, the bone filler will initially travel through the cavity(ies) created by the device(s). If desired, a practitioner can interrupt introduction of bone filler and create additional cavity(ies) by reinserting the device(s). In addition, in the event bone filler leakage occurs or is imminent, the practitioner can interrupt bone filler introduction, create additional cavity(ies) as described above, wait for the introduced/leaking bone filler to harden sufficiently, and then continue introducing bone filler. As previously described, the bone filler could comprise many different materials, or combinations of materials, with varying results.
An opening or window 700 is desirably formed in the shaft 620 a. As shown in
The expandable structure 710 may be comprised of a flexible material common in medical device applications, including, but not limited to, plastics, polyethylene, mylar, rubber, nylon, polyurethane, metals or composite materials. Desirably, the shaft 620 a will comprise a material that is more resistant to expansion than the material of the expandable structure 710, including, but not limited to, stainless steel, ceramics, composite material and/or rigid plastics. In an alternate embodiment, similar materials for the expandable structure 710 and shaft 620 a may be used, but in different thickness and/or amounts, thereby inducing the expandable structure to be more prone to expansion than the shaft 620 a material. The expandable structure 710 may be bonded directly to the shaft 620 a by various means well known in the art, including, but not limited to, means such as welding, melting, gluing or the like. In alternative embodiments, the expandable structure may be secured inside or outside of the shaft 620 a, or a combination thereof.
As previously noted, any of the cavity-forming devices 500, 600 and 600 a may be inserted through a shaft 348 positioned in a targeted bone, such as a vertebral body 105. As the device(s) enter the cancellous bone 115, they will desirably displace the bone 115 and create one or more cavities in the vertebral body. If desired, the physician can withdraw the device(s) back into the shaft 348 and reinsert as necessary to create the desired cavity(ies) in the cancellous bone 115.
In the embodiment of a cavity-forming device of
By creating one or more cavities within the cancellous bone 115, the cavity-forming devices of the present invention desirably create preferred flowpaths for the bone filler 180. In addition, the cavity-forming devices can also desirably close and/or block other natural flowpaths out of the cavity, such as veins and/or cracks in the cancellous bone. Moreover, methods and devices disclosed herein can be used to manipulate bone filler already introduced into the bone. Thus, the present invention reduces opportunities for cement leakage outside of the vertebral body and/or improves the distribution of bone filler throughout significant portions of the vertebral body. In addition, the creation of cavities and desired flowpaths described in the present invention permits the placement of biomaterial more safely, under greater control and under lower pressures.
In addition to the specific uses described above, the cavity-forming devices and methods described herein would also be well-suited for use in treating and/or reinforcing weakened, diseased and/or fractured bones and other organs in various locations throughout the body. For example, the disclosed devices and methods could be used to deliver reinforcing materials and/or medications, such as cancer drugs, replacement bone cells, collagen, bone matrix, demineralized calcium, and other materials/medications, directly to a fractured, weakened and/or diseased bone, thereby increasing the efficacy of the materials, reinforcing the weakened bone and/or speed healing. Moreover, injection of such materials into one bone within a body could permit the medication/material to migrate and/or be transported to other bones and/or organs in the body, thereby improving the quality of bones and/or other organs not directly injected with the materials and/or medications.
Other embodiments and uses of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. All documents referenced herein are specifically and entirely incorporated by reference. The specification and examples should be considered exemplary only with the true scope and spirit of the invention indicated by the following claims. As will be easily understood by those of ordinary skill in the art, variations and modifications of each of the disclosed embodiments can be easily made within the scope of the claims.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US1965653 *||1 Nov 1932||10 Jul 1934||Kennedy James W||Dilator|
|US3049125 *||28 Mar 1960||14 Ago 1962||Kriwkowitsch George||Nose packing device|
|US3091237 *||16 May 1960||28 May 1963||Clawson N Skinner||Facial muscle and tissue conditioning device|
|US3648294 *||4 Feb 1970||14 Mar 1972||Shahrestani Esfandiar||Endoprostheses, especially for hip joints|
|US3766924 *||26 Ene 1972||23 Oct 1973||Matburn Ltd||Nasal tampons|
|US3800788 *||12 Jul 1972||2 Abr 1974||White N||Antral catheter for reduction of fractures|
|US3875595 *||15 Abr 1974||8 Abr 1975||Froning Edward C||Intervertebral disc prosthesis and instruments for locating same|
|US3889665 *||7 Mar 1973||17 Jun 1975||Nat Res Dev||Apparatus and method for pressurizing gap-filling cement to a concavely relieved site in a bone|
|US4018230 *||2 Abr 1975||19 Abr 1977||Kazuo Ochiai||Cervical dilator|
|US4083369 *||2 Jul 1976||11 Abr 1978||Manfred Sinnreich||Surgical instruments|
|US4205683 *||17 Mar 1978||3 Jun 1980||Victory Engineering Corporation||Adapter for inflating balloon catheter|
|US4274163 *||16 Jul 1979||23 Jun 1981||The Regents Of The University Of California||Prosthetic fixation technique|
|US4313434 *||17 Oct 1980||2 Feb 1982||David Segal||Fracture fixation|
|US4367816 *||10 Jun 1981||11 Ene 1983||Wilkes Kenneth R||Tear strip for gas sterilizable package and package|
|US4369772 *||28 Abr 1980||25 Ene 1983||University Of Florida||Method for strengthening a fractured bone|
|US4399814 *||27 Abr 1981||23 Ago 1983||Massachusetts Institute Of Technology||Method and apparatus for pressure-coated bones|
|US4432358 *||22 Ene 1982||21 Feb 1984||Fixel Irving E||Compression hip screw apparatus|
|US4462394 *||3 May 1982||31 Jul 1984||Howmedica, Inc.||Intramedullary canal seal for cement pressurization|
|US4466435 *||4 Sep 1981||21 Ago 1984||Murray William M||Bone cement nozzle and method|
|US4467479 *||5 Feb 1982||28 Ago 1984||Brody Garry S||Method of surgically repairing an injured human joint and a prosthetic device therefor|
|US4494535 *||24 Jun 1981||22 Ene 1985||Haig Armen C||Hip nail|
|US4562598 *||1 Abr 1982||7 Ene 1986||Mecron Medizinische Produkte Gmbh||Joint prosthesis|
|US4595006 *||16 Ago 1982||17 Jun 1986||Burke Dennis W||Apparatus for cemented implantation of prostheses|
|US4637396 *||26 Oct 1984||20 Ene 1987||Cook, Incorporated||Balloon catheter|
|US4653469 *||7 Ago 1985||31 Mar 1987||Nippon Sanso Kabushiki Kaisha||Vacuum-heat-insulated cooking utensil and method of manufacturing same|
|US4685447 *||25 Mar 1985||11 Ago 1987||Pmt Corporation||Tissue expander system|
|US4686973 *||12 Oct 1984||18 Ago 1987||Dow Corning Corporation||Method of making an intramedullary bone plug and bone plug made thereby|
|US4772287 *||20 Ago 1987||20 Sep 1988||Cedar Surgical, Inc.||Prosthetic disc and method of implanting|
|US4842585 *||7 Dic 1987||27 Jun 1989||B. Braun Melsungen Ag||Steel cannula for spinal and peridural anaesthesia|
|US4892550 *||30 Dic 1985||9 Ene 1990||Huebsch Donald L||Endoprosthesis device and method|
|US4896662 *||30 Nov 1987||30 Ene 1990||Pfizer Hospital Products Group, Inc.||Sealing device for introducing cement into a bone canal|
|US4909252 *||26 May 1988||20 Mar 1990||The Regents Of The Univ. Of California||Perfusion balloon catheter|
|US4932975 *||16 Oct 1989||12 Jun 1990||Vanderbilt University||Vertebral prosthesis|
|US4987892 *||21 Dic 1989||29 Ene 1991||Krag Martin H||Spinal fixation device|
|US5002576 *||6 Jun 1989||26 Mar 1991||Mecron Medizinische Produkte Gmbh||Intervertebral disk endoprosthesis|
|US5015255 *||10 May 1989||14 May 1991||Spine-Tech, Inc.||Spinal stabilization method|
|US5049132 *||8 Ene 1990||17 Sep 1991||Cordis Corporation||Balloon catheter for delivering therapeutic agents|
|US5100390 *||22 Oct 1990||31 Mar 1992||Norma A. Lubeck||Lubeck spinal catheter needle|
|US5102413 *||14 Nov 1990||7 Abr 1992||Poddar Satish B||Inflatable bone fixation device|
|US5108404 *||15 Ago 1990||28 Abr 1992||Arie Scholten||Surgical protocol for fixation of bone using inflatable device|
|US5116305 *||23 Oct 1991||26 May 1992||Abiomed, Inc.||Curved intra aortic balloon with non-folding inflated balloon membrane|
|US5122134 *||2 Feb 1990||16 Jun 1992||Pfizer Hospital Products Group, Inc.||Surgical reamer|
|US5127912 *||5 Oct 1990||7 Jul 1992||R. Charles Ray||Sacral implant system|
|US5137512 *||11 Dic 1990||11 Ago 1992||Scimed Life Systems, Inc.||Multisegment balloon protector for dilatation catheter|
|US5147366 *||1 Mar 1990||15 Sep 1992||Pfizer Hospital Products Group, Inc.||Pressurization of bone cement surrounding an endoprosthesis|
|US5176638 *||22 May 1991||5 Ene 1993||Don Michael T Anthony||Regional perfusion catheter with improved drug delivery control|
|US5176683 *||22 Abr 1991||5 Ene 1993||Kimsey Timothy P||Prosthesis press and method of using the same|
|US5176692 *||9 Dic 1991||5 Ene 1993||Wilk Peter J||Method and surgical instrument for repairing hernia|
|US5290306 *||29 Nov 1989||1 Mar 1994||Cordis Corporation||Puncture resistant balloon catheter|
|US5295994 *||15 Nov 1991||22 Mar 1994||Bonutti Peter M||Active cannulas|
|US5303718 *||15 Ene 1992||19 Abr 1994||Milan Krajicek||Method and device for the osteosynthesis of bones|
|US5330429 *||8 Ene 1993||19 Jul 1994||Toray Industries, Inc.||Catheter with a balloon reinforced with composite yarn|
|US5331975 *||2 Mar 1990||26 Jul 1994||Bonutti Peter M||Fluid operated retractors|
|US5380290 *||16 Abr 1992||10 Ene 1995||Pfizer Hospital Products Group, Inc.||Body access device|
|US5383932 *||27 Abr 1993||24 Ene 1995||Johnson & Johnson Professional, Inc.||Absorbable medullary plug|
|US5423850 *||17 Nov 1993||13 Jun 1995||Berger; J. Lee||Balloon compressor for internal fixation of bone fractures|
|US5425710 *||26 Oct 1993||20 Jun 1995||Medtronic, Inc.||Coated sleeve for wrapping dilatation catheter balloons|
|US5441538 *||12 Abr 1993||15 Ago 1995||Bonutti; Peter M.||Bone implant and method of securing|
|US5445639 *||13 Ago 1991||29 Ago 1995||Spine-Tech, Inc.||Intervertebral reamer construction|
|US5480400 *||1 Oct 1993||2 Ene 1996||Berger; J. Lee||Method and device for internal fixation of bone fractures|
|US5514143 *||27 Nov 1991||7 May 1996||Apogee Medical Products, Inc.||Apparatus and method for use during surgery|
|US5514153 *||14 Feb 1994||7 May 1996||General Surgical Innovations, Inc.||Method of dissecting tissue layers|
|US5522790 *||14 Mar 1994||4 Jun 1996||Origin Medsystems, Inc.||Retraction apparatus and methods for endoscopic surgery|
|US5522846 *||10 Mar 1995||4 Jun 1996||Bonutti; Peter M.||Suture anchor|
|US5527343 *||23 Nov 1994||18 Jun 1996||Bonutti; Peter M.||Suture anchor|
|US5527624 *||5 Abr 1995||18 Jun 1996||The Lubrizol Corporation||Process for preparing sintered shapes and compositions used therein|
|US5531856 *||13 Ago 1993||2 Jul 1996||Origin Medsystems, Inc.||Endoscopic inflatable retraction devices|
|US5540711 *||10 Mar 1995||30 Jul 1996||General Surgical Innovations, Inc.||Apparatus and method for developing an anatomic space for laparoscopic procedures with laparoscopic visualization|
|US5545136 *||5 Ene 1995||13 Ago 1996||Berger; J. Lee||Grooved catheter director apparatus|
|US5545222 *||8 Jul 1994||13 Ago 1996||Bonutti; Peter M.||Method using human tissue|
|US5549388 *||22 May 1995||27 Ago 1996||Wilkes; Kenneth R.||Pleated sterilization pouch|
|US5549679 *||1 Mar 1995||27 Ago 1996||Kuslich; Stephen D.||Expandable fabric implant for stabilizing the spinal motion segment|
|US5601590 *||4 Abr 1995||11 Feb 1997||General Surgical Innovations, Inc.||Expandable cannulas|
|US5755690 *||21 Oct 1994||26 May 1998||C. R. Bard||Multiple layer high strength balloon for dilatation catheter|
|US5772681 *||2 Mar 1994||30 Jun 1998||Metra Aps||Dilation catheter|
|US5788703 *||2 Ene 1996||4 Ago 1998||Allo Pro Ag||Apparatus for the placement of a medullary space blocker|
|US5792044 *||22 Mar 1996||11 Ago 1998||Danek Medical, Inc.||Devices and methods for percutaneous surgery|
|US5865728 *||21 Nov 1995||2 Feb 1999||Origin Medsystems, Inc.||Method of using an endoscopic inflatable lifting apparatus to create an anatomic working space|
|US5893840 *||24 Abr 1996||13 Abr 1999||Medtronic, Inc.||Releasable microcapsules on balloon catheters|
|US5928162 *||31 Mar 1997||27 Jul 1999||Symbiosis Corporation||Tissue core biopsy cannula|
|US6017305 *||29 Ene 1996||25 Ene 2000||General Surgical Innovations, Inc.||Method of retracting bones|
|US6036682 *||2 Dic 1997||14 Mar 2000||Scimed Life Systems, Inc.||Catheter having a plurality of integral radiopaque bands|
|US6036711 *||18 Feb 1998||14 Mar 2000||United States Surgical Corporation||Reusable cannula|
|US6048346 *||13 Ago 1997||11 Abr 2000||Kyphon Inc.||Systems and methods for injecting flowable materials into bones|
|US6066154 *||22 Ene 1997||23 May 2000||Kyphon Inc.||Inflatable device for use in surgical protocol relating to fixation of bone|
|US6117456 *||16 Oct 1996||12 Sep 2000||Etex Corporation||Methods and products related to the physical conversion of reactive amorphous calcium phosphate|
|US6235043 *||23 Ene 1997||22 May 2001||Kyphon, Inc.||Inflatable device for use in surgical protocol relating to fixation of bone|
|US6241734 *||14 Ago 1998||5 Jun 2001||Kyphon, Inc.||Systems and methods for placing materials into bone|
|US6248110 *||9 Jun 1997||19 Jun 2001||Kyphon, Inc.||Systems and methods for treating fractured or diseased bone using expandable bodies|
|US6280450 *||23 Jul 1998||28 Ago 2001||Rex Medical, Lp||Breast surgery method and apparatus|
|US6280456 *||23 Sep 1999||28 Ago 2001||Kyphon Inc||Methods for treating bone|
|US6440138 *||6 Abr 1998||27 Ago 2002||Kyphon Inc.||Structures and methods for creating cavities in interior body regions|
|US6582446 *||28 Abr 2000||24 Jun 2003||J. Alexander Marchosky||Method and apparatus for percutaneous osteoplasty|
|US6607544 *||19 Oct 1999||19 Ago 2003||Kyphon Inc.||Expandable preformed structures for deployment in interior body regions|
|US20020010472 *||15 Dic 2000||24 Ene 2002||Kuslich Stephen D.||Tool to direct bone replacement material|
|US20020032447 *||28 Ago 2001||14 Mar 2002||Stuart Weikel||Tools and methods for creating cavities in bone|
|US20020099385 *||25 Oct 2001||25 Jul 2002||Kyphon Inc.||Systems and methods for reducing fractured bone using a fracture reduction cannula|
|US20030050702 *||13 Sep 2001||13 Mar 2003||J - Lee Berger||Spinal grooved director with built in balloon and method of using same|
|US20030120664 *||21 Dic 2001||26 Jun 2003||Davidson Joel R.||Method and apparatus for reassembly of data blocks within a network processor|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US7666226||15 Ago 2006||23 Feb 2010||Benvenue Medical, Inc.||Spinal tissue distraction devices|
|US7666227||15 Ago 2006||23 Feb 2010||Benvenue Medical, Inc.||Devices for limiting the movement of material introduced between layers of spinal tissue|
|US7670374||15 Ago 2006||2 Mar 2010||Benvenue Medical, Inc.||Methods of distracting tissue layers of the human spine|
|US7670375||15 Ago 2006||2 Mar 2010||Benvenue Medical, Inc.||Methods for limiting the movement of material introduced between layers of spinal tissue|
|US7785368||15 Ago 2006||31 Ago 2010||Benvenue Medical, Inc.||Spinal tissue distraction devices|
|US7955391||15 Feb 2010||7 Jun 2011||Benvenue Medical, Inc.||Methods for limiting the movement of material introduced between layers of spinal tissue|
|US7963993||15 Feb 2010||21 Jun 2011||Benvenue Medical, Inc.||Methods of distracting tissue layers of the human spine|
|US7967864||15 Feb 2010||28 Jun 2011||Benvenue Medical, Inc.||Spinal tissue distraction devices|
|US7967865||15 Feb 2010||28 Jun 2011||Benvenue Medical, Inc.||Devices for limiting the movement of material introduced between layers of spinal tissue|
|US8057544||15 Ago 2006||15 Nov 2011||Benvenue Medical, Inc.||Methods of distracting tissue layers of the human spine|
|US8366773||25 Ene 2008||5 Feb 2013||Benvenue Medical, Inc.||Apparatus and method for treating bone|
|US8454617||4 Jun 2013||Benvenue Medical, Inc.||Devices for treating the spine|
|US8535327||16 Mar 2010||17 Sep 2013||Benvenue Medical, Inc.||Delivery apparatus for use with implantable medical devices|
|US8556978||15 Nov 2011||15 Oct 2013||Benvenue Medical, Inc.||Devices and methods for treating the vertebral body|
|US8591507||31 Ene 2013||26 Nov 2013||Dfine, Inc.||Methods and systems for use in controlling tissue ablation volume by temperature monitoring|
|US8591583||21 Feb 2008||26 Nov 2013||Benvenue Medical, Inc.||Devices for treating the spine|
|US8663226||30 Sep 2009||4 Mar 2014||Dfine, Inc.||System for use in treatment of vertebral fractures|
|US8758349||13 Oct 2009||24 Jun 2014||Dfine, Inc.||Systems for treating a vertebral body|
|US8801787||16 Jun 2011||12 Ago 2014||Benvenue Medical, Inc.||Methods of distracting tissue layers of the human spine|
|US8808376||25 Mar 2009||19 Ago 2014||Benvenue Medical, Inc.||Intravertebral implants|
|US8814873||22 Jun 2012||26 Ago 2014||Benvenue Medical, Inc.||Devices and methods for treating bone tissue|
|US8864760||11 Mar 2013||21 Oct 2014||Dfine, Inc.||Methods and systems for use in controlling tissue ablation volume by temperature monitoring|
|US8882836||18 Dic 2012||11 Nov 2014||Benvenue Medical, Inc.||Apparatus and method for treating bone|
|US8961553 *||15 Sep 2008||24 Feb 2015||Crosstrees Medical, Inc.||Material control device for inserting material into a targeted anatomical region|
|US8961609||26 Sep 2013||24 Feb 2015||Benvenue Medical, Inc.||Devices for distracting tissue layers of the human spine|
|US8968408||24 Abr 2013||3 Mar 2015||Benvenue Medical, Inc.||Devices for treating the spine|
|US8979929||16 Jun 2011||17 Mar 2015||Benvenue Medical, Inc.||Spinal tissue distraction devices|
|US9044338||12 Mar 2013||2 Jun 2015||Benvenue Medical, Inc.||Spinal tissue distraction devices|
|US9066808||20 Feb 2009||30 Jun 2015||Benvenue Medical, Inc.||Method of interdigitating flowable material with bone tissue|
|US9113974||16 Ene 2014||25 Ago 2015||Dfine, Inc.||System for use in treatment of vertebral fractures|
|US9113988||12 Feb 2007||25 Ago 2015||Crosstrees Medical, Inc.||Method for inserting medicine into animal tissue|
|US9125671||29 Abr 2011||8 Sep 2015||Dfine, Inc.||System for use in treatment of vertebral fractures|
|US20110054416 *||15 Sep 2008||3 Mar 2011||Hollowell Daniel R||Material control device for inserting material into a targeted anatomical region|
|WO2009036466A1 *||15 Sep 2008||19 Mar 2009||Crosstrees Medical Inc||Material control device for inserting material into a targeted anatomical region|
|Clasificación de EE.UU.||606/92|
|Clasificación internacional||A61M25/00, A61F2/46, A61B19/00, A61F2/28, A61L27/00, A61F2/30, A61B17/16, A61B19/02, A61F2/00, A61B17/00, A61B17/56, A61F2/44, A61B17/88|
|Clasificación cooperativa||A61F2002/4624, A61B2017/00261, A61B17/8855, A61F2002/4635, A61B19/0271, A61B2019/462, A61B2017/00557, A61F2/4601, A61F2310/00353, A61F2002/4662, A61F2250/0098, A61F2002/2835, A61B2017/00464, A61F2002/3008, A61B17/3472, A61B17/1671, A61B2017/00867, A61F2/44, A61F2002/30581, A61B2019/0219, A61B2017/00539, A61B17/8805, A61B19/54, A61B17/1604, A61F2002/4602|
|Clasificación europea||A61B17/88C2B, A61B17/16S4, A61B17/16C, A61F2/46A|
|5 Feb 2007||AS||Assignment|
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT,WAS
Free format text: SECURITY AGREEMENT;ASSIGNOR:KYPHON INC.;REEL/FRAME:018875/0574
Effective date: 20070118
|14 Mar 2008||AS||Assignment|
Owner name: KYPHON, INC.,CALIFORNIA
Free format text: TERMINATION/RELEASE OF SECURITY INTEREST;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:020666/0869
Effective date: 20071101
|9 May 2008||AS||Assignment|
Owner name: MEDTRONIC SPINE LLC,CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:KYPHON INC;REEL/FRAME:020993/0042
Effective date: 20080118
|9 Jun 2008||AS||Assignment|
Owner name: KYPHON SARL,SWITZERLAND
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDTRONIC SPINE LLC;REEL/FRAME:021070/0278
Effective date: 20080325
|26 Mar 2015||AS||Assignment|
Owner name: ORTHOPHOENIX, LLC, TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KYPHON SARL;REEL/FRAME:035307/0018
Effective date: 20130425